JPRN-UMIN000052859已完成Unknown
Measurement of luteinizing hormone surge in vaginal discharge -Open-label study- - Measurement of luteinizing hormone surge in vaginal discharge -Open-label study
Miura Clinic, Medical Corporation Kanonkai0 个研究点目标入组 40 人开始时间: 2023年11月22日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 40years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •(1) Subjects with a history of diabetes, liver disease, renal disease, gastrointestinal disease, heart disease, respiratory disease, peripheral vascular disease, or other serious disease (2) Subjects who have undergone surgery on the digestive organs (3) Subjects with abnormal liver function and renal function test values (4) Subjects with diseases currently being treated (5) Subjects who are allergic to foods and drugs (6) Subjects with anemia symptoms (7) Women undergoing infertility treatment and those who have been diagnosed with polycystic ovary syndrome (8)Use of hormonal contraceptives, use of hormone replacement therapy, fertility drugs, artificial insemination, IVF, ICSI Those who are undergoing other medical treatments, such as adjuvant fertility therapy. (9) Subjects wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating female subjects (10) Subjects or a close family member who works for Cranebio Co., Ltd., Unicharm Co., Ltd., or their affiliates. (11) Subjects who play intense sports and subjects who are on a diet (12) Subjects with extremely irregular eating habits (13) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (14) Subjects who are continuously receiving medical treatment (including OTC and prescription drugs) (15) Subjects who drink more than 60 g of average daily pure alcohol (16) Subjects who smoke an average of 21 or more cigarettes a day (17) Subjects who are participating in or will participate in other clinical trials at the start of this study (18) Other subjects judged by the investigator or the investigator to be inappropriate for the examination
研究者
相似试验
尚未招募
3 期
Development of valid immunoassay methods for Luteinising Hormone (LH) in urine.ACTRN12609000300279Sydney South Western Area Health Service (SSWAHS)4
招募中
3 期
Detection of recombinant human luteinising hormone (rLH) as a doping agentACTRN12608000181303Sydney South Western Area Health Service (SSWAHS)64
尚未招募
不适用
Detection of Indirect Androgen Doping with a GnRH Analog (Leuprolide)ACTRN12609000629235Sydney South West Area Health Authority (SSWAHS)16
撤回
4 期
ptake of levonorgestrel releasing intrauterine system (LNG-IUS, Mirena 'Registered Trademark') at caesarean sectioFertilitycaesarean sectionACTRN12617000509369Mackay Hospital and Health Service100
招募中
不适用
THE IMPORTANCE OF ANTIMULLERIAN HORMONE IN DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROMECTRI/2017/02/007800Sanjay Gandhi Postgraduate Institute of medical Sciences280